Subject(s)
Atherosclerosis/etiology , Atherosclerosis/microbiology , Chlamydophila Infections/complications , Chlamydophila Infections/microbiology , Chlamydophila pneumoniae/isolation & purification , Coronary Disease/etiology , Coronary Disease/microbiology , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Young AdultABSTRACT
The family Chlamydiaceae (order Chlamydiales, phylum Chlamydiae) comprises important, obligate intracellular bacterial pathogens of humans and animals. Subdivision of the family into the two genera Chlamydia and Chlamydophila has been discussed controversially during the past decade. Here, we have revisited the current classification in the light of recent genomic data and in the context of the unique biological properties of these microorganisms. We conclude that neither generally used 16S rRNA sequence identity cut-off values nor parameters based on genomic similarity consistently separate the two genera. Notably, no easily recognizable phenotype such as host preference or tissue tropism is available that would support a subdivision. In addition, the genus Chlamydophila is currently not well accepted and not used by a majority of research groups in the field. Therefore, we propose the classification of all 11 currently recognized Chlamydiaceae species in a single genus, the genus Chlamydia. Finally, we provide emended descriptions of the family Chlamydiaceae, the genus Chlamydia, as well as the species Chlamydia abortus, Chlamydia caviae and Chlamydia felis.
Subject(s)
Chlamydia/classification , Chlamydia/genetics , Chlamydophila/classification , Chlamydophila/genetics , Animals , Cluster Analysis , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , Humans , Molecular Sequence Data , Phylogeny , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNAABSTRACT
Several lines of evidence have associated Chlamydia pneumoniae with cardiovascular disease including acceleration of atherosclerotic lesion progression in hyperlipidemic animal models by infection. Many of the pro-atherogenic effects of oxidized low-density lipoprotein (ox-LDL) occur through the activation of the lectin-like ox-LDL receptor-1 (LOX-1). Chlamydia pneumoniae upregulates the expression of the LOX-1 mRNA, promotes the uptake of ox-LDL, and utilizes the LOX-1 receptor for infectivity. The overall goal of this study was to determine whether C. pneumoniae organisms upregulated LOX-1 protein expression in vascular cells and whether upregulation of pro-atherogenic factors by C. pneumoniae occurred through LOX-1. Chlamydia pneumoniae induced LOX-1 protein expression in both endothelial cells and RAW macrophages. Upregulation was prevented by preincubation of cells with LOX-1 antibody prior to infection. Similarly, C. pneumoniae upregulated protein expression of adhesion molecules, MMP-1, and MMP-3, which was mitigated by anti-LOX-1 antibody. Prior treatment of organisms with PNGase, which removes the chlamydial glycan that is N-linked to the major outer membrane, abolished C. pneumoniae upregulation of LOX-1. These studies suggest that activation of LOX-1 expression occurs through binding of the chlamydial glycan and provides one mechanism by which C. pneumoniae infection could play a role in the pathogenesis of atherosclerosis.
Subject(s)
Chlamydophila pneumoniae/pathogenicity , Host-Pathogen Interactions , Scavenger Receptors, Class E/biosynthesis , Animals , Bacterial Outer Membrane Proteins/metabolism , Cells, Cultured , Endothelial Cells/microbiology , Endothelial Cells/physiology , Gene Expression Profiling , Macrophages/microbiology , Macrophages/physiology , Matrix Metalloproteinase 1/biosynthesis , Matrix Metalloproteinase 3/biosynthesis , Mice , Polysaccharides/metabolism , Up-RegulationABSTRACT
The association of Chlamydia pneumoniae and atherosclerosis has been well documented. Recently, it has been demonstrated that C. pneumoniae up-regulates expression of the lectin-like ox-LDL receptor (LOX-1) in endothelial cells. Many of the pro-atherogenic effects of ox-LDL occur through its activation and uptake by LOX-1. This class E scavenger receptor contains a carbohydrate-recognition domain common to the C type lectin family. Previously, we have demonstrated that the major outer membrane protein of the chlamydiae is glycosylated and glycan removal abrogates infectivity of C. pneumoniae for endothelial cells. In this study, we investigated whether C. pneumoniae binds to LOX-1. The results show that 1) infection of endothelial cells by C. pneumoniae is inhibited by ligands that bind to the LOX-1 receptor, but not by ligands binding to other scavenger receptors; 2) anti-LOX-1 antibody inhibits C. pneumoniae infectivity, while antibodies against other scavenger receptors do not; 3) anti-LOX-1 antibody inhibits attachment of C. pneumoniae to endothelial cells; and 4) C. pneumoniae co-localizes with LOX-1. These effects were not observed for Chlamydia trachomatis. In conclusion, C. pneumoniae binds to the LOX-1 receptor, which is known to promote atherosclerosis.
Subject(s)
Atherosclerosis/metabolism , Atherosclerosis/microbiology , Chlamydophila pneumoniae/metabolism , Receptors, Oxidized LDL/metabolism , Scavenger Receptors, Class E/metabolism , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/pharmacology , Atherosclerosis/pathology , Cell Line , Chlamydophila pneumoniae/pathogenicity , Endothelial Cells/metabolism , Endothelial Cells/microbiology , Gene Expression Regulation, Bacterial , HeLa Cells , Humans , Lectins/metabolism , Scavenger Receptors, Class E/antagonists & inhibitors , Scavenger Receptors, Class E/immunology , Up-RegulationABSTRACT
The acute phase response to Chlamydia pneumoniae infection was analyzed over a 72 h period post-infection in C57BL/6J mice. A single intra-nasal inoculation stimulated statistically significant increases in the plasma levels of IL-2, IL-5, IL-6, IL-10, IL-12, GM-CSF, IFN-gamma, and serum amyloid A but not TNF-alpha, IL-1beta, IL-4 and serum amyloid P. There was also a decrease in the activity of the HDL protective enzyme paraoxonase as well as a reduced ability of HDL to prevent oxidation of palmitoyl-2-arachidonyl-sn-glycerol-3-phosphocholine by hydroperoxyoctadecadienoic acid at 48 and 72 h post-infection. To determine whether the C. pneumoniae induced acute phase response had any effect on atherosclerotic plaque stability, we measured the frequency of intra-plaque hemorrhage as a marker of plaque disruption in the innominate arteries of apolipoprotein E deficient mice at 29-30 weeks and 1.5-2.0 years of age. There was an increased frequency of intra-plaque hemorrhage only in the older mice infected with the live organism (8/14) as compared to mice treated with killed C. pneumoniae (2/11) or sham inoculated with PBS (2/12). These results suggest that acute phase reactant proteins produced in response to pulmonary infection with C. pneumoniae may contribute to the progression and destabilization of atherosclerotic lesions.
Subject(s)
Acute-Phase Proteins/metabolism , Atherosclerosis/pathology , Chlamydophila Infections/complications , Chlamydophila pneumoniae/immunology , Chlamydophila pneumoniae/pathogenicity , Pneumonia, Bacterial/complications , Animals , Chlamydophila Infections/immunology , Hemorrhage/chemically induced , Hemorrhage/pathology , Male , Mice , Mice, Inbred C57BL , Pneumonia, Bacterial/immunologyABSTRACT
Chlamydiae are Gram-negative obligate intracellular parasites. Chlamydia pneumoniae is a human respiratory pathogen that causes pneumonia, bronchitis, sinusitis, and pharyngitis. C. pneumoniae has also been associated with cardiovascular disease. C. pneumoniae can only be grown in cell culture and is more difficult to isolate from specimens than Chlamydia trachomatis. Commonly used cell lines for isolation of C. trachomatis are not sensitive for C. pneumoniae. The most sensitive cell lines for isolation of C. pneumoniae are HL and HEp-2. Centrifugation of the inoculum onto the monolayer and inclusion of cycloheximide in the medium enhance isolation. Inclusions are smaller than those of other chlamydiae and are visualized by staining with FITC-conjugated genus- or C. pneumoniae-specific monoclonal antibodies. Slow expansion and use of a small inoculum are key to successful culture. Infectious organisms can be purified by use of Hypaque-76 gradients to titers >1 x 10(8)/ml.
Subject(s)
Bacteriological Techniques , Chlamydophila pneumoniae/growth & development , Chlamydophila pneumoniae/isolation & purification , Cell Line , Centrifugation, Density Gradient/methods , Child , Chlamydophila Infections/microbiology , Culture Media , Humans , Young AdultABSTRACT
Chlamydia pneumoniae, a common respiratory pathogen, has been associated with cardiovascular disease. C. pneumoniae infection accelerates atherosclerotic lesion development in hyperlipidemic animals. Retinoic acid, an anti-oxidant, inhibits infection of endothelial cells by C. pneumoniae. The present study demonstrated that retinoic acid suppresses the acceleration of foam cell lesion development induced by C. pneumoniae in hyperlipidemic C57BL/6J mice. Retinoic acid treatment had no effect on foam cell lesion development in uninfected animals. Lung infection and duration was decreased in treated mice, suggesting one mechanism by which retinoic acid reduces C. pneumoniae-accelerated foam cell lesion formation in hyperlipidemic mice.
Subject(s)
Atherosclerosis/drug therapy , Chlamydophila pneumoniae/drug effects , Chlamydophila pneumoniae/pathogenicity , Disease Models, Animal , Foam Cells/drug effects , Tretinoin/administration & dosage , Animals , Atherosclerosis/microbiology , Atherosclerosis/pathology , Humans , Hyperlipidemias/drug therapy , Hyperlipidemias/microbiology , Lung/microbiology , Male , Mice , Mice, Inbred C57BL , Pneumonia, Bacterial/drug therapy , Pneumonia, Bacterial/microbiology , Pneumonia, Bacterial/pathology , Specific Pathogen-Free Organisms , Treatment Outcome , Tretinoin/pharmacologyABSTRACT
The efficacy of rifalazil and other benzoxazinorifamycins was tested in a mouse model of lung infection against Chlamydia pneumoniae. Rifalazil and six related new chemical entities all showed efficacy after one dose per day for 3 days at either 3 or 1 mg/kg of body weight.
Subject(s)
Chlamydia Infections/drug therapy , Chlamydophila pneumoniae/drug effects , Lung/drug effects , Rifamycins/pharmacology , Animals , Anti-Bacterial Agents/pharmacology , Disease Models, Animal , Lung/microbiology , Male , Mice , Microbial Sensitivity TestsABSTRACT
Chlamydia pneumoniae is a common respiratory pathogen, which activates macrophages to induce inflammatory cytokines that may promote atherosclerosis. However, the antigens that induce macrophage activation have not been well defined. In the current study, three chlamydial proteins which are recognized during human infection, outer membrane protein 2 (OMP2) and two 53-kDa proteins (Cpn 0980 and Cpn 0809), were investigated to determine whether they activate macrophages and, if they do, what mechanism they use for this activation. It was shown that these three proteins could (i) induce expression of tumor necrosis factor alpha (TNF-alpha) and tissue factor and (ii) induce phosphorylation of p44/42 mitogen-activated protein kinases (MAPK) and activation of early growth response factor 1 (Egr-1). Control proteins, the N-terminal fragment of polymorphic membrane protein 8 and the thioredoxin portion of the fusion protein, had no effect on macrophages. Treatment of cells with a MEK1/2 inhibitor, U0126, dramatically reduced the phosphorylation of ERK, activation of Egr-1, and expression of TNF-alpha in macrophages treated with recombinant proteins. Toll-like receptors (TLRs) act as sensors for microbial antigens and can signal via the MAPK pathway. Chlamydial protein-induced expression of TNF-alpha was significantly reduced in macrophages lacking TLR2 or TLR4. These findings suggest that C. pneumoniae may activate macrophages through OMP2, Cpn 0980, and Cpn 0809 in addition to cHSP60 and that activation occurs via TLR2 or TLR4, Egr-1, and MAPK pathways.
Subject(s)
Bacterial Proteins/metabolism , Bacterial Proteins/pharmacology , Chlamydophila pneumoniae/metabolism , Macrophages/drug effects , Macrophages/metabolism , Tumor Necrosis Factor-alpha/metabolism , Animals , Cell Line , Early Growth Response Protein 1/genetics , Early Growth Response Protein 1/metabolism , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , Extracellular Signal-Regulated MAP Kinases/metabolism , Gene Expression Regulation , Mice , Mitogen-Activated Protein Kinase 1/metabolism , Phosphorylation , Recombinant Proteins , Thromboplastin/genetics , Thromboplastin/metabolism , Tumor Necrosis Factor-alpha/geneticsABSTRACT
Chlamydia pneumoniae is a human respiratory pathogen that has also been associated with cardiovascular disease. C. pneumoniae infection accelerates atherosclerotic plaque development in hyperlipidemic animals and promotes oxidation of low density lipoprotein in vitro. All-trans-retinoic acid (ATRA), an antioxidant, has been shown to inhibit C. pneumoniae infectivity for endothelial cells by preventing binding of the organism to the M6P/IGF2 receptor on the cell surface. This current study investigates whether ATRA similarly affects C. pneumoniae infectivity of epithelial cells, which are the primary site of infection in the respiratory tract, and the effects on intracellular growth in both endothelial and epithelial cells. Because ATRA binds to both the nuclear retinoid acid receptor (RAR) and the M6P/IGF2 receptor, 4-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl]benzoic acid (TTNPB), an ATRA analog, which binds to the RAR but not the M6P/IGF2 receptor was used to differentiate the receptor mediating the effects of ATRA. The results of this study showed two separate effects of ATRA. The first effect is through interaction with the M6P/IGF2 receptor on the cell surface preventing attachment of the organism (inhibition by ATRA but not TTNPB) in endothelial cells and the second is through the nuclear receptor (inhibition by both ATRA and TTNPB) which inhibits growth in both epithelial and endothelial cells.
Subject(s)
Chlamydophila pneumoniae/immunology , Endothelial Cells/microbiology , Receptor, IGF Type 2/antagonists & inhibitors , Receptors, Retinoic Acid/antagonists & inhibitors , Tretinoin/immunology , Bacterial Adhesion/drug effects , Cell Line , Chlamydophila pneumoniae/growth & development , Cytoplasm/microbiology , Cytoplasm/ultrastructure , Humans , Inclusion Bodies/microbiology , Inclusion Bodies/ultrastructureABSTRACT
Interactions between monocytes/macrophages and endothelial cells play an important role in the pathogenesis of atherosclerosis, and the adherence of monocytes to the arterial endothelium is one of the early events in atherogenesis. In the present study, peritoneal macrophages harvested from green fluorescent protein (GFP) transgenic mice were used to analyze how Chlamydia pneumoniae infection affects the adherence of GFP-macrophages to mouse endothelial cells in vitro and to the aorta from normolipidemic and hyperlipidemic mice ex vivo. In vitro studies showed that C. pneumoniae-infected GFP-macrophages adhered better than uninfected macrophages to endothelial cells and GFP-macrophages adhered better to infected than uninfected endothelial cells. The ex vivo studies showed that C. pneumoniae-infected macrophages adhered better than uninfected macrophages to aortas from both normolipidemic and hyperlipidemic C57BL/6J mice and apolipoprotein E (ApoE)-deficient mice. In contrast, adherence of C. pneumoniae-infected macrophages to the aortas of intercellular adhesion molecule 1 (ICAM-1) knockout mice was not enhanced, suggesting that ICAM-1 is crucial for activation of the adherence of C. pneumoniae-infected macrophages to the endothelium. In conclusion, the present study defined a homing mechanism by which C. pneumoniae promotes the adherence of mononuclear phagocytes to the endothelium at the site of atherosclerotic lesion formation to promote the progression of atherosclerosis.
Subject(s)
Aorta/microbiology , Cell Adhesion , Chlamydophila pneumoniae/physiology , Endothelial Cells/microbiology , Macrophages/microbiology , Animals , Apolipoproteins E/deficiency , Cell Line , Cells, Cultured , Female , Humans , Intercellular Adhesion Molecule-1/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, TransgenicABSTRACT
Previous studies have shown that the chlamydial glycan contains a high-mannose oligosaccharide, which mediates attachment and infectivity of the organism. Removal of the glycan decreases infectivity in vitro and in vivo. The present study demonstrates that simultaneous inoculation of chlamydial organisms and a ligand that prevents glycan binding reduces lung burden in infected animals.
Subject(s)
Chlamydia Infections/metabolism , Chlamydia trachomatis/metabolism , Chlamydophila pneumoniae/metabolism , Lung/microbiology , Acrylic Resins/pharmacology , Animals , Attachment Sites, Microbiological/drug effects , Bacterial Adhesion/drug effects , Chlamydia Infections/microbiology , Chlamydia Infections/prevention & control , Chlamydia trachomatis/pathogenicity , Chlamydophila pneumoniae/pathogenicity , Ligands , Lung Diseases/metabolism , Lung Diseases/microbiology , Lung Diseases/prevention & control , Mannans/pharmacology , Mannose/metabolism , Mice , Models, Animal , Oligosaccharides/metabolism , Pneumonia, Bacterial/metabolism , Pneumonia, Bacterial/microbiology , Pneumonia, Bacterial/prevention & control , Receptor, IGF Type 2/metabolismABSTRACT
Previous studies determined that the Chlamydia glycan contains a high-mannose oligosaccharide, which is involved in attachment and infectivity of the organism, and that removal of the glycan decreases infectivity in vitro. The present study demonstrates that treatment of the organism with N-glycanase decreases or ablates infectivity in vivo.
Subject(s)
Chlamydia Infections/prevention & control , Lung Diseases/prevention & control , Oligosaccharides/metabolism , Polysaccharides/physiology , Animals , Chlamydia Infections/drug therapy , Chlamydia Infections/etiology , Mice , Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase/pharmacologyABSTRACT
Infections caused by the obligate intracellular pathogen Chlamydia trachomatis have a marked impact on human health. C. trachomatis serovariants are the leading cause of bacterial sexually transmitted disease and infectious preventable blindness. Despite decades of effort, there is no practical vaccine against C. trachomatis diseases. Here we report that all C. trachomatis reference serotypes responsible for sexually transmitted disease and blinding trachoma synthesize a highly conserved surface-exposed antigen termed polymorphic membrane protein D (PmpD). We show that Ab specific to PmpD are neutralizing in vitro. We also present evidence that Ab against serovariable-neutralizing targets, such as the major outer membrane protein, block PmpD neutralization. This finding suggests that a decoy-like immune evasion strategy may be active in vivo whereby immunodominant type-specific surface antigens block the neutralizing ability of species-common PmpD Ab. Collectively, these results show that PmpD is a previously uncharacterized C. trachomatis species-common pan-neutralizing target. Moreover, a vaccine protocol using recombinant PmpD to elicit neutralizing Ab in the absence of immunodominant type-specific Ab might be highly efficacious and surpass the level of protection achieved through natural immunity.
Subject(s)
Antigens/immunology , Bacterial Outer Membrane Proteins/immunology , Chlamydia trachomatis/immunology , Animals , Antibodies/immunology , Bacterial Outer Membrane Proteins/classification , Bacterial Outer Membrane Proteins/genetics , Blood Proteins/immunology , Cell Line , Chlamydia trachomatis/classification , Chlamydia trachomatis/genetics , Chlamydia trachomatis/ultrastructure , Genome, Bacterial/genetics , Humans , Lipopolysaccharides/pharmacology , Microscopy, Electron , Neutralization Tests , Rabbits , TitrimetryABSTRACT
Several mechanisms for attachment and entry of Chlamydia have been proposed. We previously determined that the major outer membrane protein of Chlamydia trachomatis is glycosylated with a high-mannose oligosaccharide, and a similar structure inhibited the attachment and infectivity of C. trachomatis in epithelial cells. Because insulin-like growth factor 2 (IGF2) was shown to enhance the infectivity of Chlamydia pneumoniae but not C. trachomatis in endothelial cells, a hapten inhibition assay was used to analyze whether the mannose 6-phosphate (M6P)/IGF2 receptor that also binds M6P could be involved in infection of endothelial cells (HMEC-1) by Chlamydia. M6P and mannose 6-phosphate-poly[N-(2-hydroxyethyl)-acrylamide] (M6P-PAA) inhibited the infectivity of C. pneumoniae AR-39, but not C. trachomatis serovar UW5 or L2, while mannan inhibited the growth of C. trachomatis, but not C. pneumoniae. Using metabolically labeled organisms incubated with cells at 4 degrees C (organisms attach but do not enter) or at 37 degrees C (organisms attach and are internalized), M6P-PAA was shown to inhibit attachment and internalization of C. pneumoniae in endothelial cells but did not inhibit attachment or internalization of C. trachomatis serovar E or L2. These findings indicate that C. pneumoniae can utilize the M6P/IGF2 receptor and that the use of this receptor for attachment and entry differs between C. pneumoniae and C. trachomatis.
Subject(s)
Chlamydophila Infections/metabolism , Chlamydophila pneumoniae/metabolism , Endothelial Cells/microbiology , Receptor, IGF Type 2/metabolism , Alkaline Phosphatase/pharmacology , Animals , Anti-Bacterial Agents/pharmacology , Chlamydia Infections/immunology , Chlamydia Infections/metabolism , Chlamydia trachomatis/immunology , Chlamydia trachomatis/metabolism , Chlamydia trachomatis/pathogenicity , Chlamydophila Infections/drug therapy , Chlamydophila Infections/immunology , Chlamydophila pneumoniae/drug effects , Chlamydophila pneumoniae/immunology , Chlamydophila pneumoniae/pathogenicity , Endothelial Cells/immunology , Endothelial Cells/metabolism , Haptens/immunology , Humans , MiceABSTRACT
Chlamydia pneumoniae is a common respiratory pathogen that is associated with an increased risk of cardiovascular disease. However, the mechanisms by which C. pneumoniae contributes to cardiovascular disease have not been determined yet. C. pneumoniae infection may accelerate the death of cells within atherosclerotic lesions and contribute to the formation of unstable lesions. To test this hypothesis, the impact of C. pneumoniae infection on the death of lipid-loaded mouse macrophages was investigated. It was observed that RAW 264.7 cells are highly susceptible to the toxic effects of oxidized low-density lipoprotein (LDL) and exhibit markers of cell death within 24 h of treatment with as little as 5 microg/ml oxidized LDL. Subsequent infection with either live C. pneumoniae or heat-killed or UV-inactivated C. pneumoniae at a low multiplicity of infection for 24 to 72 h stimulated both additional binding of annexin V and the uptake of propidium iodide. Thus, C. pneumoniae augments the effects of oxidized LDL on cell death independent of a sustained infection. However, unlike oxidized LDL, C. pneumoniae infection does not activate caspase 3 or induce formation of the mitochondrial transition pore or the fragmentation of DNA, all of which are classical markers of apoptosis. Furthermore, primary bone marrow macrophages isolated from mice deficient in Toll-like receptor 2 (TLR-2) but not TLR-4 are resistant to C. pneumoniae-induced death. These data suggest that C. pneumoniae kills cells by a caspase-independent pathway and that the process is potentially mediated by activation of TLR-2.
Subject(s)
Caspases/physiology , Chlamydophila pneumoniae/pathogenicity , Lipoproteins, LDL/toxicity , Macrophages/drug effects , Animals , Apoptosis , Arteriosclerosis/etiology , Calcium/metabolism , Cells, Cultured , Mice , Mice, Inbred C57BL , Phosphatidylserines/metabolism , Receptors, Immunologic/physiology , Toll-Like Receptor 2ABSTRACT
Chlamydiae are obligate intracellular gram-negative bacteria and are dependent on the host cell for ATP. Thus, chlamydial infection may alter the intracellular levels of ATP and affect all energy-dependent processes within the cell. We have shown that both live C. pneumoniae and inactivated C. pneumoniae induce markers of cell death prior to completion of the bacterial growth cycle. As depletion of ATP could account for the observed increase in cell death, the effects of C. pneumoniae on ATP concentrations within mouse macrophages were investigated. Live, heat-killed, and UV-inactivated C. pneumoniae cultures (at multiplicities of infection [MOIs] of 0.01, 0.1, and 1.0) were incubated with mouse bone marrow macrophages isolated from C57BL/6J mice and mice deficient in Toll-like receptors. Treatment of the macrophages with both live and inactivated C. pneumoniae increased the ATP content of the cells. In cells infected with live C. pneumoniae, the increase was inversely proportional to the MOI. In cells treated with inactivated C. pneumoniae, the increase in ATP content was smaller than that induced by infection with live organisms and was proportional to the MOI. The increase in ATP content early in the developmental cycle was independent of the growth of C. pneumoniae, while sustained induction required live organisms. The capacity of C. pneumoniae to increase the ATP content was ablated in macrophages deficient in expression of either Toll-like receptor 2 or the Toll-like receptor accessory protein MyD88. In contrast, no effect was observed in macrophages lacking expression of Toll-like receptor 4.
Subject(s)
Adenosine Triphosphate/analysis , Chlamydophila pneumoniae/pathogenicity , Macrophages/chemistry , Receptors, Immunologic/physiology , Animals , Macrophages/microbiology , Mice , Mice, Inbred C57BL , Signal Transduction , Toll-Like Receptor 2ABSTRACT
The role of tumor necrosis factor alpha (TNF-alpha) in Chlamydia pneumoniae atherogenesis was evaluated in TNF-alpha p55 receptor-deficient C57BL/6J mice fed a high-fat/high-cholesterol diet. No acceleration of atherosclerotic lesion development was observed in infected mice compared to uninfected mice, indicating that TNF-alpha plays a role in the acceleration of atherosclerosis by C. pneumoniae.
Subject(s)
Arteriosclerosis/microbiology , Arteriosclerosis/physiopathology , Chlamydophila pneumoniae/pathogenicity , Hyperlipidemias/microbiology , Hyperlipidemias/physiopathology , Tumor Necrosis Factor-alpha/metabolism , Animals , Chlamydophila Infections/microbiology , Chlamydophila Infections/physiopathology , Chlamydophila pneumoniae/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Receptors, Tumor Necrosis Factor/genetics , Receptors, Tumor Necrosis Factor, Type I , Tumor Necrosis Factor Decoy ReceptorsABSTRACT
Previous studies demonstrated that the high-mannose oligosaccharide N linked to the Chlamydia major outer membrane protein inhibited the attachment and infectivity of the organism. The present study showed that cleavage of the glycan with N-glycanase decreased the attachment and infectivity of chlamydial organisms in human epithelial and endothelial cells.
Subject(s)
Bacterial Adhesion , Chlamydia/physiology , Endothelial Cells/microbiology , Epithelial Cells/microbiology , Glycoside Hydrolases/metabolism , Oligosaccharides/metabolism , Cell Line , Chlamydia/classification , Humans , Polysaccharides/metabolismABSTRACT
Macrophages play a critical role in both innate and acquired immunity because of their unique ability to internalize, kill, and degrade bacterial pathogens through the process of phagocytosis. The adaptor protein, amphiphysin IIm, participates in phagocytosis and is transiently associated with early phagosomes. Certain pathogens, including Chlamydia pneumoniae, have evolved mechanisms to subvert macrophage phagosome maturation and, thus, are able to survive within these cells. We report here that, although amphiphysin IIm is usually only transiently associated with the phagosome, it is indefinitely retained on vacuoles containing C. pneumoniae. Under these wild-type conditions, C. pneumoniae do not elicit significant nitric oxide (NO) production and are not killed. Abrogation of amphiphysin IIm function results in C. pneumoniae-induced NO production and in the sterilization of the vacuole. The data suggest that C. pneumoniae retains amphiphysin IIm on the vacuole to survive within the macrophage.